Most recent carbon footprint: 6,846,866 tCO2e.
AstraZeneca commits to reduce absolute scope 1 and 2 GHG emissions 98% by FY2026 from a FY2015 base year, and to reduce absolute scope 3 GHG emissions 50% by FY2030 from a FY2019 base year.
Reduction methods available: Yes
Most recent carbon footprint: 380,641 tCO2e.
AVEVA Group PLC commits to reduce absolute scope 1 and 2 GHG emissions 90% by FY2030 from a FY2020 base year.
Reduction methods available: Yes
Most recent carbon footprint: 16,449 tCO2e.
AVIVA PLC commits to reduce its Scope 1 and 2 emissions by 90% and Scope 3 emissions by 70% by 2030 from a 2019 base year.
Reduction methods available: Yes
Most recent carbon footprint: 798,211 tCO2e.
AbbVie commits to reduce absolute scope 1 and 2 GHG emissions 42.0% by 2030 from its 2021 baseline year
Reduction methods available: Yes
Most recent carbon footprint: 1,405,000 tCO2e.
Abbott commits to reduce absolute scope 1 and 2 GHG emissions 30% by 2030 from its 2018 baseline year.
Reduction methods available: Yes
Most recent carbon footprint: 400,457 tCO2e.
Accenture, commits to becoming Net Zero by 2025, from its 2016 baseline year.
Reduction methods available: Yes
Most recent carbon footprint: 688 tCO2e.
Addleshaw Goddard Llp, commits to reduce scope 1, 2 and 3 GHG emissions 50% by 2030, from its 2019 baseline year.
Reduction methods available: Yes
Most recent carbon footprint: 39,328,134 tCO2e.
Air Liquide commits to reduce absolute scope 1 and 2 GHG emissions 35% by 2035 from its 2021 baseline year.
Reduction methods available: Yes
